A- A A+

Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020

V Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, MJ Cole, A Saei, B Oguti, K Munro, S Wallace, PD Kirwan, M Shrotri, A Vusirikala, S Rokadiya, M Kall, M Zambon, M Ramsay, T Brooks, SIREN Study Group, CS Brown, MA Chand, S Hopkins

medRxiv 2021.01.13.21249642; doi.org/10.1101/2021.01.13.21249642 

This article is a preprint and has not been certified by peer review


SARS-CoV-2: Reinfektionen beim medizinischen Personal weiterhin selten

London – Die Gefahr des medizinischen Personals, sich nach einer überstandenen Infektion ein zweites Mal mit SARS-CoV-2 anzustecken, ist weiterhin gering. Dies geht aus einer neuen Analyse der britischen SIREN-Studie hervor, deren Stichtag allerdings vor das Auftreten der neuen Variante B.1.1.7 fällt. Die Ergebnisse wurden auf medRxiv (2021; DOI: 10.1101/2021.01.13.21249642) veröffentlicht. (aerzteblatt.de, 18.01.2021)


Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication. 

Farsalinos, K., Bagos, P.G., Giannouchos, T. et al. 

Harm Reduct J 18, 9 (2021). doi.org/10.1186/s12954-020-00437-5


NIDA. People With SUDs Have Increased Risk for COVID-19 and Worse Outcomes

This Study reported;

People with a

+ substance use disorder (SUD) at any time in their lives are 1.5 times more likely to contract COVID-19 than those without an SUD, and those with a recent SUD are more than 8 times more likely. 

+ People with opioid use disorder (OUD) and African Americans are at particularly high risk for COVID-19. 

+ COVID-19 patients with SUDs are more likely to require hospitalization and to die from COVID-19 than those without SUD, with patients with OUD and African American patients at greatest risk.

(NIDA Notes, USA, 13.01.2021)


USA:. HS Expands Access to Treatment for Opioid Use Disorder 

The U.S. Department of Health and Human Services is publishing Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder*, to expand access to medication-assisted treatment (MAT) by exempting physicians from certain certification requirements needed to prescribe buprenorphine for opioid use disorder (OUD) treatment. (HHS, USA, Januar 2021)


COVID-19 and Healthcare Workers: A Systematic Review and Metaanalysis. 

Gholami M, Fawad I, Shadan S, Rowaiee R, Ghanem H, Omer A, Ho HSB. 

Int J Infect Dis. 2021 Jan 11:S1201-9712(21)00023-0. doi: 10.1016/j.ijid.2021.01.013. Epub ahead of print. PMID: 33444754; PMCID: PMC7798435.


Covid Reference - 6th International Edition

Bernd-Sebastian Kamps und Christoph Hoffmann

Steinhäuser Verlag, 2021

13 January 2021. Finally, after 10 weeks, we have published the next edition of COVID Reference – The COVID Textbook (453 pages; we apologize for the delay). We dedicate this edition to Anthony Fauci who never tired of defending science.


For better or for worse? A pre–post exploration of the impact of the COVID‐19 lockdown on cannabis users. 

Cousijn, J., Kuhns, L., Larsen, H., and Kroon, E. (2021) 

Addiction, doi.org/10.1111/add.15387. 


Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020. 

Jones CM, Guy GP Jr, Board A.

Drug Alcohol Depend. 2021 Jan 6;219:108486. doi: 10.1016/j.drugalcdep.2020.108486. Epub ahead of print. PMID: 33421802; PMCID: PMC7787058.


ICD-10-GM Version 2021 mit Aktualisierung vom 11. November 2020

Bitte beachten Sie: Wegen neuer U-Kodes in Zusammenhang mit COVID-19 im Bereich U08-U10 wurden alle Dateien zum Systematischen Verzeichnis der ICD-10-GM Version 2021 aktualisiert. (DIMDI, Januar 2021)


Bislang keine Hinweise auf vermehrte Nebenwirkungen nach Coronaimpfungen

Langen – Das bundeseigene Paul-Ehrlich-Institut (PEI) hat bislang keine Hinweise auf möglicherweise vermehrt auftretende Nebenwirkungen bei Impfungen gegen das Coronavirus SARS-CoV-2. (aerzteblatt.de, 14.01.2021)


Science Denial and COVID Conspiracy Theories: Potential Neurological Mechanisms 

and Possible Responses. 


JAMA. 2020;324:2255-2256. 


Cannabis and COVID-19: Reasons for Concern. 

van Laar MW, Oomen PE, van Miltenburg CJA, Vercoulen E, Freeman TP, Hall WD. 

Front Psychiatry. 2020 Dec 21;11:601653. doi: 10.3389/fpsyt.2020.601653. PMID: 33408655; PMCID: PMC7779403.


Online Event. Heroin Assisted Treatment 

Wed, 27 January 2021, 14:00 – 15:30 GMT. Middlesbrough has been operating England's only Heroin Assisted Treatment programme for 18mths with some fantastic early findings. The programme has seen dramatic increase in individual participants health and well being and a significant reduction in crime. Come and listen to Daniel describe the programme in detail and talk about the impact its having in the lives of people who use it, their families and communities. (Recovering Justice, UK, 2021)


Why are drug-related deaths among women increasing in Scotland? A mixed-methods analysis of possible explanations,

Emily J. Tweed, Rebekah G. Miller, Joe Schofield, Lee Barnsdale & Catriona Matheson (2020) 

Drugs: Education, Prevention and Policy, DOI: 10.1080/09687637.2020.1856786


Nichtsubstanzgebundene Abhängigkeiten im Kindes- und Jugendalter

Internet, Computerspiele und Soziale Medien

Non-substance addiction in childhood and adolescence—the Internet, computer games and social media

Geisel, Olga; Lipinski, Anneke; Kaess, Michael

Dtsch Arztebl Int 2021; 118: 14-22; DOI: 10.3238/arztebl.m2021.0002


The COVID-19 Vaccine Communication Handbook. A practical guide for improving vaccine communication and fighting misinformation. 

Lewandowsky, S., Cook, J., Schmid, P., Holford, D. L., Finn, A., Leask, J., Thomson, A., Lombardi, D., Al-Rawi, A. K., Amazeen, M. A., Anderson, E. C., Armaos, K. D., Betsch, C., Bruns, H. H. B., Ecker, U. K. H., Gavaruzzi, T., Hahn, U., Herzog, S., Juanchich, M., Kendeou, P., Newman, E. J., Pennycook, G., Rapp, D. N., Sah, S., Sinatra, G. M., Tapper, K., Vraga, E. K (2021). 


Impfmythen begegnen: Handbuch bietet Kommunikationsleitfaden

Berlin – Ein Handbuch zum Thema COVID-19-Impfung hat ein Team aus Wissenschaft­lern sowie Freiwilligen unterschiedlicher akademischer Disziplinen erstellt. Es richtet sich an Ärzte, Journalisten, Angehörige der Pflegeberufe, politische Entscheidungsträger sowie Forschende, Lehrende, Studierende und Eltern. (aerzteblatt.de, 13.01.2021)


Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective. 

van Santen, D.K., Coutinho, R.A., van den Hoek, A. et al. Harm Reduct J 18, 2 (2021). doi.org/10.1186/s12954-020-00444-6


Cooking heroin the Turkish way: chemical investigation on an unusual heroin preparation method.

Dahm, G., Allar, C., Schaaf, R. et al. 

Harm Reduct J 18, 8 (2021). doi.org/10.1186/s12954-020-00457-1


Harm reduction in Europe: a framework for civil society-led monitoring. 

Rigoni, R., Tammi, T., van der Gouwe, D. et al.

Harm Reduct J 18, 3 (2021). doi.org/10.1186/s12954-020-00451-7


Peer-assisted injection as a harm reduction measure in a supervised consumption service: a qualitative study of client experiences. 

Pijl, E., Oosterbroek, T., Motz, T. et al. 

Harm Reduct J 18, 5 (2021). doi.org/10.1186/s12954-020-00455-3


Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis. 

Antoniou, T., Martins, D., Campbell, T., Tadrous, M., Munro, C., Leece, P., Mamdani, M., Juurlink, D. N., and Gomes, T. (2020) 

Addiction, doi.org/10.1111/add.15324.


A critical narrative inquiry to understand the impacts of an overdose prevention site on the lives of site users. 

Oudshoorn, A., Sangster Bouck, M., McCann, M. et al. 

Harm Reduct J 18, 6 (2021). doi.org/10.1186/s12954-020-00458-0


Racial Justice Requires Ending the War on Drugs.

Brian D. Earp, Jonathan Lewis, Carl L. Hart & with Bioethicists and Allied Professionals for Drug Policy Reform (2021) 

The American Journal of Bioethics, DOI: 10.1080/15265161.2020.1861364


Psychiatry Trainees' Attitudes, Knowledge, and Training in Addiction Psychiatry—A European Survey

Front. Psychiatry, 08 January 2021 | doi.org/10.3389/fpsyt.2020.585607


Bericht über die Methadon-Behandlung des niedersächsischen Jugendberatungszentrums Hannover des DPWV

Dr.med. Jürgen Lotze, Marie-Louise Rabe, Hartmut Stichtenoth

Niedersächsisches Ärzteblatt, Nr. 11. 46.Jahrgang, 7. Juni 1973, 359-362


Risk of Substance Use Disorder and Its Associations With Comorbidities and Psychotropic Agents in Patients With Autism. 

Huang J, Yang F, Chien W, et al. 

JAMA Pediatr. Published online January 04, 2021. doi:10.1001/jamapediatrics.2020.5371


Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada. 

Morin KA, Acharya S, Eibl JK, Marsh DC. 

Int J Drug Policy. 2020 Dec 23;90:103088. doi: 10.1016/j.drugpo.2020.103088. Epub ahead of print. PMID: 33385974.


Changing trends in psychiatric emergency service admissions during the COVID-19 outbreak: Report from a worldwide epicentre. 

Gómez-Ramiro M, Fico G, Anmella G, Vázquez M, Sagué-Vilavella M, Hidalgo-Mazzei D, Pacchiarotti I, Garriga M, Murru A, Parellada E, Vieta E. 

J Affect Disord. 2020 Dec 27;282:26-32. doi: 10.1016/j.jad.2020.12.057. Epub ahead of print. PMID: 33387743; PMCID: PMC7765763.